Thus, despite the clinical relevance of syndecan-1 in the prognosis of diseases such as multiple myeloma [52], and sepsis [53], syndecan-1 does not appear to be important in PD-induced pathology. This evidence concerns the gene SDC1 and AL amyloidosis.